🚨 ESKAPE Pathogens: The Superbugs Every FRCPath Candidate Must Know

Published on: July 26, 2025

Author: Team FRCPathPrep

Category: Microbial Pathogenesis, Antimicrobial Resistance, Exam Topics

When studying for the FRCPath Medical Microbiology exam, understanding the major threats in antimicrobial resistance (AMR) is non-negotiable. At the heart of this is a notorious group of hospital-acquired superbugs known collectively as the ESKAPE pathogens.

These organisms have been labelled WHO Priority Pathogens, not just because they’re dangerous—but because they’re increasingly untreatable.

🧠 What Are ESKAPE Pathogens?

The acronym ESKAPE stands for six bacterial genera/species that are particularly adept at evading the effects of antibiotics and infection control protocols:

Letter	Organism	Resistance Highlights
E	Enterococcus faecium	Vancomycin-resistant (VRE), cephalosporin-resistant due to altered PBPs
S	Staphylococcus aureus	MRSA (mecA-mediated PBP2a), VRSA (vanA gene transfer)
K	Klebsiella pneumoniae	ESBL, AmpC, Carbapenemase producers (KPC, NDM), capsule overproducers
A	Acinetobacter baumannii	XDR/MDR phenotypes, OXA-type carbapenemases
P	Pseudomonas aeruginosa	Intrinsic resistance, efflux pumps, porin loss, carbapenemase production
E	Enterobacter spp.	AmpC β-lactamase producers, may acquire carbapenemases

📚 Why Should You Care as an FRCPath Candidate?

1. OSPE & SAQ Goldmine:ESKAPE organisms frequently appear in:

   • Resistance mechanism identification

   • Infection control scenarios

   • Treatment decision trees

2. Treatment Complexity:Managing infections caused by ESKAPE organisms often requires:

   • Combination therapies

   • Use of last-resort antibiotics (e.g., daptomycin, colistin, ceftazidime-avibactam)

3. Infection Control Focus:

   • Most are multi-drug resistant (MDR) or extensively drug-resistant (XDR).

   • Linked with outbreaks in ICUs, transplant units, and oncology wards.

📝 How to Study This for the Exam

• Memorise the acronym ESKAPE and the core resistance for each.

• Practice MCQs and SAQs on:

  • Beta-lactamases (ESBL, AmpC, KPC, NDM)

  • Resistance due to porin loss or efflux

  • Clinical scenarios (VAP, catheter-associated infections, etc.)

• Review UKHSA/BSAC guidelines for antimicrobial choices in resistant infections.

💡 Mnemonic: "They ESKAPE our drugs and control."

🔍 Quick Facts to Remember:

• ESKAPE pathogens = majority of ICU-related HAIs

• Major contributors to global AMR burden

• Target of antimicrobial stewardship and vaccine research

📖 FRCPathPrep Tip:

“Frame each organism in terms of its:🔹 Intrinsic resistance🔹 Acquired resistance🔹 Clinical significance🔹 Control measures”

✅ What’s Next?

👉 Want ready-to-practice MCQs and OSPE cases on ESKAPE?🎯 Check out our FRCPath Part 1 MCQ Bank and Part 2 Casebook at www.FRCPathPrep.com